79 related articles for article (PubMed ID: 16095205)
1. [Normal pressure hydrocephalus after subarachnoid hemorrhage and TGF-beta1 induced mouse hydrocephalus].
Tada T; Hongo K
No Shinkei Geka; 2005 Aug; 33(8):751-7. PubMed ID: 16095205
[No Abstract] [Full Text] [Related]
2. [Normal pressure hydrocephalus (NPH) after subarachnoid hemorrhage].
Miyazaki H; Siokawa Y
Nihon Rinsho; 2006 Nov; 64 Suppl 8():581-3. PubMed ID: 17471649
[No Abstract] [Full Text] [Related]
3. Comparison of cerebrospinal fluid biomarkers between idiopathic normal pressure hydrocephalus and subarachnoid hemorrhage-induced chronic hydrocephalus: a pilot study.
Lee JH; Park DH; Back DB; Lee JY; Lee CI; Park KJ; Kang SH; Cho TH; Chung YG
Med Sci Monit; 2012 Dec; 18(12):PR19-25. PubMed ID: 23197244
[TBL] [Abstract][Full Text] [Related]
4. Intraventricular administration of hepatocyte growth factor treats mouse communicating hydrocephalus induced by transforming growth factor beta1.
Tada T; Zhan H; Tanaka Y; Hongo K; Matsumoto K; Nakamura T
Neurobiol Dis; 2006 Mar; 21(3):576-86. PubMed ID: 16352434
[TBL] [Abstract][Full Text] [Related]
5. [Our results in the surgical treatment of the normal pressure hydrocephalus. A review of 20 cases (author's transl)].
Morales Ramos F; Narros A; Albert P
Rev Esp Otoneurooftalmol Neurocir; 1975; 33(193):97-108. PubMed ID: 1215631
[No Abstract] [Full Text] [Related]
6. Inhibition of matrix metalloproteinase on hepatic transforming growth factor beta1 and caspase-3 activation in hemorrhage.
Maitra SR; Bhaduri S; El-Maghrabi MR; Shapiro MJ
Acad Emerg Med; 2005 Sep; 12(9):797-803. PubMed ID: 16141011
[TBL] [Abstract][Full Text] [Related]
7. Rapid closure of midgestational excisional wounds in a fetal mouse model is associated with altered transforming growth factor-beta isoform and receptor expression.
Goldberg SR; McKinstry RP; Sykes V; Lanning DA
J Pediatr Surg; 2007 Jun; 42(6):966-71; discussion 971-3. PubMed ID: 17560204
[TBL] [Abstract][Full Text] [Related]
8. Latent TGF-beta1-transduced CD4+ T cells suppress the progression of allergic encephalomyelitis.
Murano M; Xiong X; Murano N; Salzer JL; Lafaille JJ; Tsiagbe VK
J Leukoc Biol; 2006 Jan; 79(1):140-6. PubMed ID: 16244108
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural analysis of a murine model of congenital hydrocephalus produced by overexpression of transforming growth factor-beta1 in the central nervous system.
Aliev G; Miller JP; Leifer DW; Obrenovich ME; Shenk JC; Smith MA; Lamanna JC; Perry G; Lust DW; Cohen AR
J Submicrosc Cytol Pathol; 2006; 38(2-3):85-91. PubMed ID: 17784635
[TBL] [Abstract][Full Text] [Related]
10. Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients.
Rota E; Bellone G; Rocca P; Bergamasco B; Emanuelli G; Ferrero P
Neurol Sci; 2006 Apr; 27(1):33-9. PubMed ID: 16688597
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways.
Otsuka G; Agah R; Frutkin AD; Wight TN; Dichek DA
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):737-43. PubMed ID: 16373605
[TBL] [Abstract][Full Text] [Related]
12. High CSF transforming growth factor beta levels after subarachnoid haemorrhage: association with chronic communicating hydrocephalus.
Douglas MR; Daniel M; Lagord C; Akinwunmi J; Jackowski A; Cooper C; Berry M; Logan A
J Neurol Neurosurg Psychiatry; 2009 May; 80(5):545-50. PubMed ID: 19066194
[TBL] [Abstract][Full Text] [Related]
13. [Chronic adult hydrocephalus. a review].
Jensen TS
Ugeskr Laeger; 1974 Dec; 137(1):10-15. PubMed ID: 4454094
[No Abstract] [Full Text] [Related]
14. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 upregulation is independent of angiotensin in paraquat-induced lung fibrosis.
Chen CM; Chou HC; Hsu HH; Wang LF
Toxicology; 2005 Dec; 216(2-3):181-7. PubMed ID: 16182431
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 induces the non-classical secretion of peroxiredoxin-I in A549 cells.
Chang JW; Lee SH; Lu Y; Yoo YJ
Biochem Biophys Res Commun; 2006 Jun; 345(1):118-23. PubMed ID: 16677601
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of transforming growth factor-beta1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy.
Dai J; Losy F; Guinault AM; Pages C; Anegon I; Desgranges P; Becquemin JP; Allaire E
Circulation; 2005 Aug; 112(7):1008-15. PubMed ID: 16103255
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral-mediated TGF-beta1 inhibition in a mouse model of myelofibrosis inhibit bone marrow fibrosis development.
Gastinne T; Vigant F; Lavenu-Bombled C; Wagner-Ballon O; Tulliez M; Chagraoui H; Villeval JL; Lacout C; Perricaudet M; Vainchenker W; Benihoud K; Giraudier S
Exp Hematol; 2007 Jan; 35(1):64-74. PubMed ID: 17198875
[TBL] [Abstract][Full Text] [Related]
19. Remission of collagen-induced arthritis is associated with high levels of transforming growth factor-beta expression in the joint.
Marinova-Mutafchieva L; Gabay C; Funa K; Williams RO
Clin Exp Immunol; 2006 Nov; 146(2):287-93. PubMed ID: 17034581
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II increases intrarenal transforming growth factor-beta1 in rats submitted to sodium overload independently of blood pressure.
Rosón MI; Cao G; Della Penna S; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE
Hypertens Res; 2008 Apr; 31(4):707-15. PubMed ID: 18633183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]